Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free ONCSQ Stock Alerts

OncoSec Medical (ONCSQ) Competitors

Compare

ONCSQ vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

Should you buy OncoSec Medical stock or one of its competitors? OncoSec Medical's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does OncoSec Medical compare to 60 Degrees Pharmaceuticals?

OncoSec Medical (NASDAQ:ONCSQ) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

60 Degrees Pharmaceuticals has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than OncoSec Medical. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for OncoSec Medical. 60 Degrees Pharmaceuticals' average media sentiment score of 1.93 beat OncoSec Medical's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
OncoSec Medical Neutral
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

How does OncoSec Medical compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and OncoSec Medical (NASDAQ:ONCSQ) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
OncoSec Medical N/A N/A N/A

In the previous week, Biofrontera had 3 more articles in the media than OncoSec Medical. MarketBeat recorded 3 mentions for Biofrontera and 0 mentions for OncoSec Medical. Biofrontera's average media sentiment score of 0.96 beat OncoSec Medical's score of 0.00 indicating that Biofrontera is being referred to more favorably in the media.

Company Overall Sentiment
Biofrontera Positive
OncoSec Medical Neutral

Biofrontera has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Summary

Biofrontera beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

How does OncoSec Medical compare to Calithera Biosciences?

Calithera Biosciences (NASDAQ:CALA) and OncoSec Medical (NASDAQ:ONCSQ) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calithera BiosciencesN/AN/A-$39.65MN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Calithera Biosciences has a beta of -1.23, suggesting that its stock price is 223% less volatile than the broader market. Comparatively, OncoSec Medical has a beta of -30.04, suggesting that its stock price is 3,104% less volatile than the broader market.

In the previous week, Calithera Biosciences had 1 more articles in the media than OncoSec Medical. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for OncoSec Medical. Calithera Biosciences' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Calithera Biosciences Neutral
OncoSec Medical Neutral

Company Net Margins Return on Equity Return on Assets
Calithera BiosciencesN/A N/A N/A
OncoSec Medical N/A N/A N/A

Summary

Calithera Biosciences and OncoSec Medical tied by winning 2 of the 4 factors compared between the two stocks.

How does OncoSec Medical compare to Cingulate?

OncoSec Medical (NASDAQ:ONCSQ) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Cingulate had 2 more articles in the media than OncoSec Medical. MarketBeat recorded 2 mentions for Cingulate and 0 mentions for OncoSec Medical. Cingulate's average media sentiment score of 1.44 beat OncoSec Medical's score of 0.00 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
OncoSec Medical Neutral
Cingulate Positive

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Cingulate beats OncoSec Medical on 2 of the 2 factors compared between the two stocks.

How does OncoSec Medical compare to Comera Life Sciences?

Comera Life Sciences (NASDAQ:CMRAW) and OncoSec Medical (NASDAQ:ONCSQ) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
OncoSec Medical N/A N/A N/A

Comera Life Sciences has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
OncoSec Medical Neutral

Summary

Comera Life Sciences beats OncoSec Medical on 1 of the 1 factors compared between the two stocks.

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

Export
MetricOncoSec MedicalPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.83B$7.03B$13.06B
Dividend YieldN/A2.69%2.56%10.62%
P/E Ratio0.00779.61270.8525.39
Price / SalesN/A747.83597.9088.46
Price / CashN/A15.0328.8738.47
Price / BookN/A10.4011.096.51
Net Income-$34.18M$2.78B$3.45B$347.22M

OncoSec Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$0.00N/AN/A40
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+42.1%		N/AN/A$0.00$1.00MN/A2
BFRIW
Biofrontera
N/A$0.03
+28.0%		N/A-75.2%$0.00$43.20MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
flat		N/A-84.4%$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ONCSQ) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel